Aprepitant/Fosaprepitant Dimeglumine and C1 esterase inhibitor recombinant Intravenous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and C1 esterase inhibitor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-C1 esterase inhibitor, human Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-C1 Inhibitor (Human)
- Aprepitant/Fosaprepitant Dimeglumine-C1 Inhibitor (Human) (Berinert)
- Aprepitant/Fosaprepitant Dimeglumine-C1 Inhibitor (Human) (Cinryze)
- Aprepitant/Fosaprepitant Dimeglumine-C1 Inhibitor (Human) (Haegarda)
- Aprepitant/Fosaprepitant Dimeglumine-C1 Inhibitor (Recombinant)
- C1 esterase inhibitor recombinant Intravenous-Apresazide
- C1 esterase inhibitor recombinant Intravenous-Apresoline
- C1 esterase inhibitor recombinant Intravenous-Apresoline Injection
- C1 esterase inhibitor recombinant Intravenous-Apri
- C1 esterase inhibitor recombinant Intravenous-Apriso
- C1 esterase inhibitor recombinant Intravenous-Aprizio Pak